Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl B Scheidweiler

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Clinical Chemistry|November 5, 2013
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?Nathalie A Desrosiers, Dayong Lee, Marta Concheiro-Guisan, et al.
Addiction (Abingdon, England)|March 29, 2011
Relative performance of common biochemical indicators in detecting cigarette smokingGina F Marrone, Diaa M Shakleya, Karl B Scheidweiler, et al.
Forensic Science International|May 8, 2007
Excretion of Delta9-tetrahydrocannabinol in sweatMarilyn A Huestis, Karl B Scheidweiler, Takeshi Saito, et al.
Clinical Chemistry|September 10, 2013
First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometryAriane Wohlfarth, Shaokun Pang, Mingshe Zhu, et al.
Clinical Chemistry|December 1, 2016
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis IntakeMatthew N Newmeyer, Madeleine J Swortwood, Allan J Barnes, et al.
Clinical Chemistry|February 25, 2014
Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabisNathalie A Desrosiers, Sarah K Himes, Karl B Scheidweiler, et al.
Clinical Chemistry|March 23, 2013
In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabisKarl B Scheidweiler, David M Schwope, Erin L Karschner, et al.
The AAPS Journal|August 6, 2013
First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometryAdarsh S Gandhi, Mingshe Zhu, Shaokun Pang, et al.
Therapeutic Drug Monitoring|August 24, 2011
Oral fluid nicotine markers to assess smoking status and recency of useKarl B Scheidweiler, Gina F Marrone, Diaa M Shakleya, et al.
Therapeutic Drug Monitoring|September 4, 2010
Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administrationKarl B Scheidweiler, Erin A Kolbrich Spargo, Tamsin L Kelly, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Clinical Chemistry|November 5, 2013
Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?Nathalie A Desrosiers, Dayong Lee, Marta Concheiro-Guisan, et al.
Addiction (Abingdon, England)|March 29, 2011
Relative performance of common biochemical indicators in detecting cigarette smokingGina F Marrone, Diaa M Shakleya, Karl B Scheidweiler, et al.
Forensic Science International|May 8, 2007
Excretion of Delta9-tetrahydrocannabinol in sweatMarilyn A Huestis, Karl B Scheidweiler, Takeshi Saito, et al.
Clinical Chemistry|September 10, 2013
First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometryAriane Wohlfarth, Shaokun Pang, Mingshe Zhu, et al.
Clinical Chemistry|December 1, 2016
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis IntakeMatthew N Newmeyer, Madeleine J Swortwood, Allan J Barnes, et al.
Clinical Chemistry|February 25, 2014
Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabisNathalie A Desrosiers, Sarah K Himes, Karl B Scheidweiler, et al.
Clinical Chemistry|March 23, 2013
In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabisKarl B Scheidweiler, David M Schwope, Erin L Karschner, et al.
The AAPS Journal|August 6, 2013
First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometryAdarsh S Gandhi, Mingshe Zhu, Shaokun Pang, et al.
Therapeutic Drug Monitoring|August 24, 2011
Oral fluid nicotine markers to assess smoking status and recency of useKarl B Scheidweiler, Gina F Marrone, Diaa M Shakleya, et al.
Therapeutic Drug Monitoring|September 4, 2010
Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administrationKarl B Scheidweiler, Erin A Kolbrich Spargo, Tamsin L Kelly, et al.
Pageof 7